BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supply of adalimumab to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| AbbVie Ltd | 08004972 | - | 1 lot Lot 1 | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Amgen Ltd | 02354269 | - | 1 lot Lot 1 | - |
| Biogen Idec Ltd | 01497267 | - | 1 lot Lot 1 | LOBBYIST Portland PR Limited (2 quarters) Hawthorn Advisors Limited (1 quarter) |
| Celltrion Healthcare United Kingdom Limited | 11685363 | - | 1 lot Lot 1 | - |
| Fresenius Kabi Limited | 02182135 | - | 1 lot Lot 1 | - |
| Sandoz | 01547204 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 6 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £44,618,492 initial term | 6 | AbbVie Ltd Amgen Ltd Biogen Idec Ltd Celltrion Healthcare United Kingdom Limited Fresenius Kabi Limited Sandoz | complete |
Weightings from the notice.
Government spending data: These suppliers have received £95,687,388 in 3,736 payments (over £25k) from NHS Supply Chain (DHSC-funded), Department of Health and Social Care, Guy's and St Thomas' NHS FT, University Hospitals Bristol and Weston NHS FT, Manchester University NHS Foundation Trust and 10 more public bodies (2010-08-03 to 2026-03-31).